secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2026-04-21T23:59:59+00:00
Accession:  0001708599-26-000027
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina appoints CTO, raises CEO salary to $500K, amends bylaws for Co-Chairs
----------------------------------------------------------------------------

- Srini Tenjarla, Ph.D., promoted to CTO of Serina (AL) subsidiary; salary increased to $425,000 retroactive to Mar 15, 2026.
- CEO Steve Ledger salary raised to $500,000 retroactive to Sept 9, 2024; retro payment made in lump sum Apr 2026.
- Bylaws amended to allow one or more Co-Chairs with equal authority to call special meetings and preside.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859926000027/0001708599-26-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859926000027/ser-20260415.htm
  HTML page:      https://secwatch.observer/filing/0001708599-26-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer